p.G12C KRAS mutation prevalence in non-small cell lung cancer: Contribution from interregional variability and population substructures among Hispanics
Background: The KRAS exon 2 p. G12C mutation in patients with lung adenocarcinoma has been increasing in relevance due to the development and effectiveness of new treatment medications. Studies around different populations indicate that regional variability between ethnic groups and ancestries could...
Guardado en:
Autores principales: | Alejandro Ruiz-Patiño, July Rodríguez, Andrés F. Cardona, Jenny Ávila, Pilar Archila, Hernán Carranza, Carlos Vargas, Jorge Otero, Oscar Arrieta, Lucia Zatarain-Barrón, Carolina Sotelo, Camila Ordoñez, Juan Esteban García-Robledo, Leonardo Rojas, Maritza Bermúdez, Tatiana Gámez, Diana Mayorga, Luis Corrales, Claudio Martín, Gonzalo Recondo, Luis Mas, Suraj Samtani, Luisa Ricaurte, Umberto Malapelle, Alessandro Russo, Feliciano Barrón, Nicolas Santoyo, Christian Rolfo, Rafael Rosell |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dea50884219f4b58aada2eb1e72a93c5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CRISPR and KRAS: a match yet to be made
por: Guzide Bender, et al.
Publicado: (2021) -
KRAS and NRAS genes mutations as biomarkers in the therapy of colorectal cancer and the basic methods of their detection
por: Olga I. Brovkina, et al.
Publicado: (2021) -
Oncogenic KRAS: Signaling and Drug Resistance
por: Hyeon Jin Kim, et al.
Publicado: (2021) -
Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer
por: Gongmin Zhu, et al.
Publicado: (2021) -
Comprehensive review of fetal adenocarcinoma of the lung
por: Ricaurte LM, et al.
Publicado: (2018)